Altshock-2 Trial

Details

Altshock-2 randomised patients with acute decompensated heart failure complicated by cardiogenic shock (HF-CS) to early intra-aortic balloon pump (IABP) versus standard care. It is one of the few randomised device trials conducted specifically in the HF-CS phenotype, rather than in AMI-CS. (sources/cardiogenic-shock-nejm-2026, rating: very high)

Key Facts

Contradictions / Open Questions

Connections

Sources